MedPath

Comparative study of glimepiride and nateglinide on glycemic control in patients with type 2 diabetes mellitus treated with voglibose

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000000676
Lead Sponsor
agoya University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients without type 2 diabetes 2) Patients with alcohol abuse or excessive intake of alcoholic beverages 3) Patients with severe diabetic complications* *nephropathy>=stage 3A *retinopathy>=preproliferative stage in Davis classifications 4) Patients with liver dysfunction (AST and ALT>=80 IU/L) or renal dysfunction (serum creatinie>=1.5mg/dl) 5) Patients with an allergy to any drug 6) Pregnant women and women at child bearing age and not taking adequate contraceptions 7) Patients decided to be irrelevant by the investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath